Directory
Rosa Maria Marti Laborda

Rosa Maria Marti Laborda

Degree: PhD

973 70 52 38
marti(ELIMINAR)@medicina.udl.cat

ResearcherID: http://www.researcherid.com/rid/A-2256-2010

Publications

  • MORENO, S; MAIQUES, O; Romero M; Santacana M; Gómez I; Cuevas D; Velasco A; Veà À; Macià A; Barceló C; BOIX, R; VALLS, J; GATIUS, S; CANTI, C; MATIAS-GUIU, X; SORIA, X; MARTI, RM

    Differential Immunoexpression of BRAF/V600E, Senescence Markers, PTEN, and T-type Calcium Channels in Acquired Naevi According to their Histopathological and Dermoscopic Classification.

    ACTA DERMATO-VENEREOLOGICA 101 -. .

    [doi:10.2340/actadv.v101.361]

  • Soria X; Vilardell F; Maiques Ó; Barceló C; Sisó P; de la Rosa I; Velasco A; Cuevas D; Santacana M; Gatius S; Matías-Guiu X; Rodrigo A; Macià A; Martí RM

    BRAF(V600E)

    Mutant Allele Frequency (MAF) Influences Melanoma Clinicopathologic Characteristics

    Cancers 13 -. .

    [doi:10.3390/cancers13205073]

  • Podlipnik S; Carrera C; Boada A; Richarz N; Marcoval J; Ferreres JR; Bodet D; Martí RM; Segura S; Sabat M; Dalmau J; Quintana M; Azon A; Curcó N; Formigon M; Olivella-Garcés MR; Zaballos P; Sola J; Galvany L; Baliu-Piqué C; Alegre M; Pasquali P; Malvehy J; Puig S

    Incidence of Melanoma in Catalonia, Spain, Is Rapidly Increasing in the Elderly Population. A Multicentric Cohort Study.

    Journal of Clinical Medicine 9 -. .

    [doi:10.3390/jcm9113396]

  • Rodriguez-Hernandez I; Maiques O; Kohlhammer L; Cantelli G; Perdrix-Rosell A; Monger J; Fanshawe B; Bridgeman VL; Karagiannis SN; Penin RM; Marcolval J; Marti RM; Matias-Guiu X; Fruhwirth GO; Orgaz JL; Malanchi I; Sanz-Moreno V

    WNT11-FZD7-DAAM1 signalling supports tumour initiating abilities and melanoma amoeboid invasion.

    Nature Communications 11 5315-5315. .

    [doi:10.1038/s41467-020-18951-2]

  • López-Cano C; Gutiérrez-Carrasquilla L; Barbé F; Sánchez E; Hernández M; Martí R; Ceperuelo-Mallafre V; Dalmases M; Fernández-Veledo S; Vendrell J; Hernández C; Simó R; Lecube A

    Effect of Type 2 Diabetes Mellitus on the Hypoxia-Inducible Factor 1-Alpha Expression. Is There a Relationship with the Clock Genes?

    Journal of Clinical Medicine 9 1-10. .

    [doi:10.3390/jcm9082632]

  • Lopez-Martin, JA; Fernandez, AA; Rios-Martin, JJ; Hernandez-Losa, J; Hernandez, LA; Fuentes, PC; Reina, SO; Izquierdo, EO; Marti, RM; Garcia, JS; Fabrega, BF; Peralto, JLR

    Frequency and Clinicopathological Profile Associated with BrafMutations in Patients with Advanced Melanoma in Spain

    Translational Oncology 13 -. .

    [doi:10.1016/j.tranon.2020.100750]

  • Moreno, S; Maiques, O; Gatius, S; Vea, A; Barrera, J; Barcelo, C; Santacana, M; Soria, X; Matias-Guiu, X; Marti, RM

    Descriptive study of naevus involution in a series of 74 patients with atypical naevus syndrome under SIAscopy digital follow-up

    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY 34 1210-1217. .

    [doi:10.1111/jdv.16084]

  • Sanchez, E; Mizab, C; Sauret, A; Barbe, F; Marti, R; Lopez-Cano, C; Hernandez, M; Gutierrez-Carrasquilla, L; Carmona, P; Gonzalez, J; Dalmases, M; Hernandez, C; Simo, R; Lecube, A

    Effect of Subcutaneous Insulin on Spirometric Maneuvers in Patients with Type 1 Diabetes: A Case-Control Study.

    Journal of Clinical Medicine 9 -. .

    [doi:10.3390/jcm9051249]

  • Fernandez-de-Misa, R; Hernandez-Machin, B; Combalia, A; García Muret MP; Servitje, O; Muniesa, C; Gallardo, F; Pujol, RM; Marti, RM; Ortiz-Brugues, A; Maroñas-Jiménez L; Ortiz-Romero, PL; Blanch Rius L; Izu, R; Roman, C; Cañueto J; Blanes, M; Morillo, M; Bastida, J; Peñate Y; Pérez Gala S; Espinosa Lara P; Pérez Gil A; Estrach, T

    Prognostic factors in patients with primary cutaneous anaplastic large cell lymphoma: a multicentric, retrospective analysis of the Spanish Group of Cutaneous Lymphoma

    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY 34 762-768. .

    [doi:10.1111/jdv.16006]

  • Barcelo, C; Siso, P; Maiques, O; de la Rosa, I; Marti, RM; Macia, A

    T-type calcium channels: A potential novel target in melanoma

    Cancers 12 -. .

    [doi:10.3390/cancers12020391]

  • Barceló C; Sisó P; Maiques O; García-Mulero S; Sanz-Pamplona R; Navaridas R; Megino C; Felip I; Urdanibia I; Eritja N; Soria X; Piulats JM; Penin RM; Dolcet, X; Matias-Guiu, X; Marti, RM; Macia, A

    T-Type calcium channels as potential therapeutic targets in vemurafenib-resistant BRAF V600E melanoma: TTCCs are therapy target in BRAF V600E melanoma.

    JOURNAL OF INVESTIGATIVE DERMATOLOGY 140 1253-1265. .

    [doi:10.1016/j.jid.2019.11.014]

  • Pijuan, J; Barcelo, C; Moreno, DF; Maiques, O; Siso, P; Marti, RM; Macia, A; Panosa, A

    In vitro Cell Migration, Invasion, and Adhesion Assays: From Cell Imaging to Data Analysis

    Frontiers In Cell And Developmental Biology 7 107-107. .

    [doi:10.3389/fcell.2019.00107]

Projects

  • OncoNeoVac, un nuevo enfoque inmunoterapéutico para el tratamiento del melanoma.
  • Análisis del microambiente tumoral del melanoma cutáneo asociado al perfil genético y/o a la aparición de resistencias
  • Estudio genético y análisis del secretoma del Melanoma Acral. Identificación de biomarcadores de aplicación clínica
  • "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
  • Análisis del secretoma en el melanoma humano asociado al perfil genético y a la aparición de resistencias. Identificación de biomarcadores y/o dianas terapéuticas de aplicación clínica
  • POSTDOCTORAL AECC 2017: ESTUDIO DE LA HETEROGENEIDAD TUMORAL EN EL MELANOMA HUMANO. ESTUDIO DE LAS RESISTENCIAS A FARMACOS CONVENCIONALES Y EL PROCESO AUTOFAGICO
  • ESTUDIO DE LA HETEROGENEIDAD TUMORAL EN EL MELANOMA
  • IMPLEMENTATION OF PERSONALIZE MEDICINE IN CUTANEOUS MELANOMA BASED ON GENOMIC SUSCEPTIBILITY AND TUMOR SIGNATURES: IDENTIFICATION OF NEW TARGETS FOR MELANOMA TREATMENT
  • EXPRESION DE CANALES DE CALCIO DE TIPO T EN NEOPLASIAS MELANOCÍTICAS BENIGNAS Y MALIGNAS. EVALUACION DE SU APLICICABILIDAD CLINICA COMO DIANAS TERAPEUTICAS EN EL MELANOMA
  • UNA FLOR PER A UN PROJECTE: ESTUDI DE DOS FARMACS PEL TRACTAMENT DEL MELANOMA
  • GOTTA - ALTERACIONS MOLECULARS DEL MELANOMA
  • Efecto de los inhib idores del proteasoma en células de melanoma